Aimovig Financial Assistance Guide
CHAMP has created the financial assistance guide below for anyone who has been prescribed Aimovig by their healthcare provider. Aimovig is one of three new CGRP inhibitors that were approved for the prevention of migraine in adults. If you or someone you know requires help with paying for treatment, please review the details provided below to see if you qualify for the manufacturer’s financial assistance programs and how best to access Aimovig.
Please note: This guide has not been produced or approved by the manufacturer of Aimovig. CHAMP does not endorse the use of any CGRP inhibitor over another, nor promote the use of this new class of preventive medications for everyone with migraine disease. Please consult your healthcare provider to determine if CGRP inhibitors are right for you.
Most insurance companies have added at least one or two of these CGRP inhibitors to the list of medicines they cover, but individual patients are still struggling to get the insurers to approve coverage of their prescribed CGRP inhibitor. Each pharmaceutical company is offering financial assistance programs to help cover and/or to help cover the cost of high copays. Each program is different and various programs exist to support patients with private, goverment-funded insurance, as well as the uninsured.
To help patients understand each program, the Coalition For Headache And Migraine Patients (CHAMP) has created Financial Assistance Guides for the three CGRP inhibitors. These guides have not been produced or approved by the medication manufacturers. CHAMP is not endorsing the use of any CGRP inhibitor over another, nor promoting the use of this new class of preventive medications for everyone with migraine disease. Every patient needs to consult their healthcare provider to determine if CGRP inhibitors are right for you.
I Have Been Prescribed Aimovig. What Financial Assistance Programs Exists To Help Me?
I Have a Private/Commercial Insurance Plan
This category includes insurance plans provided through an employer, purchased with subsidy support from the Affordable Care Act (Obamacare) or purchased privately.
Highlights of Aimovig Ally Access Card
If your health plan covers Aimovig, you will pay as little as $5 per month up to a $2700 annual cap. This applies to your out-of-pocket costs, including deductible, co-insurance and copayments for Aimovig. You are responsible for costs above the $2700 annual maximum. Offer expires after 12 months at which time you must re-enroll in the program to continue receiving this benefit. You should be notified at least 30 days prior to the end of the 12 month offer. However, if you do not receive that notification, please call Aimovig Ally to follow-up.
If your health plan does not cover Aimovig, or requires a Prior Authorization, you can qualify for the Bridge to Commercial Coverage Offer. Under this offer, you will receive Aimovig at no cost for up to 12 doses while insurance coverage is pursued. Once insurance coverage is approved, this offer is no longer valid, and you must call 1-833-246-6844 to stop participation.
Steps To Get Your Savings Card
Congratulations on accessing your first dose of Aimovig! Amgen will now be working behind the scenes to get your doctor to complete a prior authorization form and to get your insurance company to cover your Aimovig prescription. To be a proactive and engaged patient, you should contact your doctor's office to see if they have completed the Aimovig prior authorization form on your behalf and your insurance company to see if they will be covering your prescribed medicine. If you have questions or encounter problems, contact the Aimovig Ally team at 1-833-246-6844.
I Have Medicare, Medicaid or other Government Insurance Plan
The Aimovig Access Card is not available to patients whose medical insurance is provided by state or federal programs like Medicare, Medicaid or Tricare. This restriction is true for all three CGRP inhibitor medications.
The Federal Government does not allow people who are receiving insurance benefits through Medicare, Medicaid, etc. to use co-pay assistance, discount or savings cards offered by pharmaceutical companies. The intent is to steer patients to lower-cost generic drugs and not to support higher-cost brand-name drugs. Unfortunately, there are no generic/biosimilar medications in the class of CGRP inhibitors and won’t be for years to come.
Certain patients with Medicare Part D plans that cover Aimovig who cannot afford their out of pocket costs may be eligible to receive Aimovig at no cost from the Amgen Safety Net Foundation. It is required that you can demonstrate that:
- You are unable to afford Aimovig (See household income guidelines below)
- You are not eligible for Medicaid or Medicare’s Extra Help program
- You have fulfilled all insurance carrier guidelines and Prior
- Authorization requirements prior to applying for assistance, and
- You do not have any other financial support options
I Am Uninsured
The Aimovig Access Card is not available to patients who are uninsured.
You may be eligible to receive Aimovig at no cost from the Amgen Safety Net Foundation if you meet the following requirements:
|If you have this many people in your household||Your household income must be equal to or below this much each year|
|Each additional person||Add $21,600|
Need More Help
Where do I turn if I am not eligible for a financial assistance program?
The Patient Advocate Foundation (a CHAMP member organization) can be a helpful resource for patients and caregivers who are experiencing access challenges. PAF provides a suite of expert tips to help navigate insurance denials, appeals and common barriers at: patientadvocate.org/migrainematters.
PAF also offers one-on-one case management assistance through its dedicated Migraine Careline for people living with migraine who experience access challenges. The Migraine Careline provides assistance with navigating eligibility and enrollment in disability benefits and overcoming insurance coverage and financial burdens that impact patient access to care. All services are completely free and provided through phone and/or email communication. Visit migraine.pafcareline.org or call 866-688-3625 to speak with a case manager today.
|Pharmaceutical Company||Amgen and Novartis|
|Dosing & Administration||Option 1: 70 mg monthly injection via the SureClick® autoinjector at home.|
Option 2: 140 mg monthly injection (2 separate 70 mg injections one right after the other) via the SureClick® autoinjector at home.
Your doctor will determine which option is best for you.
|Indication||Adults living with either chronic migraine (15 or more headache days per month) or episodic migraine (fewer than 15 headache days per month).|
|Full Prescribing Information||www.pi.amgen.com/~/media/amgen/repositorysites/pi-amgen-com/aimovig/aimovig_pi_hcp_english.ashx|
|Helpline||Aimovig Ally team at 1-833-AIMOVIG (1-833-246-6844).|
|Injection Training Available||Yes, your healthcare provider should demonstrate how to use the autoinjector prior to your first use. Detailed instructions and video are available on the Aimovig website.|
|Sharps Container Available||Yes|
|Home Delivery Available||Home delivery may be available from Aimovig Ally through their patient access program or through your insurance company. Please call either Aimovig Ally or your insurance for more information.|